FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between ANG Lifesciences IPO and Penta Gold IPO.
ANG Lifesciences IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Penta Gold IPO is a SME Fixed Price Issue proposed to list at NSE SME.
ANG Lifesciences IPO | Penta Gold IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | BSE SME | NSE SME |
Lead Managers | Oneview Corporate Advisors Pvt. Ltd. | Inventure Merchant Banker Services Pvt Ltd |
Registrar | Bigshare Services Pvt Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL |
The total issue size of ANG Lifesciences IPO is up to ₹12.01 Cr whereas the issue size of the Penta Gold IPO is up to ₹13.32 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Penta Gold IPO is ₹37.00 per share.
ANG Lifesciences IPO | Penta Gold IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹80.00 per share | ₹37.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | 3000 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 15,00,800 shares | 36,00,000 shares |
Issue Size Total (Amount) | up to ₹12.01 Cr | up to ₹13.32 Cr |
ANG Lifesciences IPO opens on Aug 29, 2017, while Penta Gold IPO opens on Mar 23, 2018. The closing date of ANG Lifesciences IPO and Penta Gold IPO is Aug 31, 2017, and Mar 27, 2018, respectively.
ANG Lifesciences IPO | Penta Gold IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Aug 29, 2017 | Mar 23, 2018 |
Issue Close | Aug 31, 2017 | Mar 27, 2018 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
ANG Lifesciences IPO P/E ratio is , as compared to Penta Gold IPO P/E ratio of .
ANG Lifesciences IPO | Penta Gold IPO | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | |||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||
P/E Ratio | |||||||||||||||||||||||||||||||||
Market Cap | |||||||||||||||||||||||||||||||||
ROE | |||||||||||||||||||||||||||||||||
ROCE | |||||||||||||||||||||||||||||||||
Debt/Equity | |||||||||||||||||||||||||||||||||
EPS | |||||||||||||||||||||||||||||||||
RoNW |
In the ANG Lifesciences IPO retail investors (RII) are offered 7,12,000 shares while in Penta Gold IPO retail investors are offered 7,12,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in ANG Lifesciences IPO and 0 shares in Penta Gold IPO.
ANG Lifesciences IPO | Penta Gold IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 1,80,000 shares | |
QIB | 0 shares | 0 shares |
NII | 7,12,000 shares | 17,10,000 shares |
RII | 7,12,000 shares | 17,10,000 shares |
Employee | ||
Others | ||
Total | 14,24,000 shares | 36,00,000 shares |
ANG Lifesciences IPO subscribed in total, whereas Penta Gold IPO subscribed 0.59x.
ANG Lifesciences IPO | Penta Gold IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 1.02x | |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 0.16x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 0.59x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|